As of 8:10 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - rigel pharmaceuticals inc (RIGL)
Nominating Committee* - rigel pharmaceuticals inc (RIGL)
|Name (Connections)||Board Relationships||Title||Key Developments|
|Walter Moos Ph.D.|| 17 Relationships||Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee||Rigel Pharmaceuticals, Inc. Announces Resignation of Hollings C. Renton as Member of the Board of Directors, Effective March 30, 2014|
|Stephen Sherwin M.D.|| 168 Relationships||Director, Chairman of Finance Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee||Rigel Pharmaceuticals, Inc. Announces Senior Management Promotions|
|Peter Ringrose M.A, Ph.D.|| 64 Relationships||Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee||Daniel Magilavy Joins Rigel as Vice President of Clinical Research|
Finance Committee* - rigel pharmaceuticals inc (RIGL)
|Debt To Total Capitalization||--|
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
Sponsored Financial Commentaries